77 related articles for article (PubMed ID: 23156225)
1. [Mechanism of metastasis in cervical cancer].
Kodama J; Hiramatsu Y
Nihon Rinsho; 2012 Jun; 70 Suppl 4():100-3. PubMed ID: 23156225
[No Abstract] [Full Text] [Related]
2. [Mechanism of metastasis in cervical cancer].
Kodama J; Hiramatsu Y
Nihon Rinsho; 2004 Oct; 62 Suppl 10():78-81. PubMed ID: 15535210
[No Abstract] [Full Text] [Related]
3. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
Liu R; Pu DM; Cheng YX; Yin L
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
[TBL] [Abstract][Full Text] [Related]
4. Role of gelatinases (matrix metalloproteinases 2 and 9), vascular endothelial growth factor and endostatin on clinicopathological behaviour of rectal cancer.
Cavdar Z; Canda AE; Terzi C; Sarioglu S; Fuzun M; Oktay G
Colorectal Dis; 2011 Feb; 13(2):154-60. PubMed ID: 19888958
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between expression of matrix metalloproteinase (MMP-9) and tumor angiogenesis, cancer cell proliferation, invasion, and metastasis in invasive carcinoma of cervix].
Jiang ZQ; Zhu FC; Qu JY; Zheng X; You CL
Ai Zheng; 2003 Feb; 22(2):178-84. PubMed ID: 12600296
[TBL] [Abstract][Full Text] [Related]
6. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
7. [The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship].
Ouyang YW; Peng ZL; Yao XY; Liu SL; He YD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):330-3. PubMed ID: 15181827
[TBL] [Abstract][Full Text] [Related]
8. Expression of metastases-associated genes in cervical cancers resected in the proliferative and secretory phases of the menstrual cycle.
Formenti S; Felix J; Salonga D; Danenberg K; Pike MC; Danenberg P
Clin Cancer Res; 2000 Dec; 6(12):4653-7. PubMed ID: 11156216
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor, matrix metalloproteinases, and cyclooxygenase-2 influence prognosis of uterine cervical cancer in young women.
Noriyuki M; Sumi T; Zhi X; Misugi F; Nobeyama H; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
Int J Oncol; 2007 Sep; 31(3):531-6. PubMed ID: 17671679
[TBL] [Abstract][Full Text] [Related]
10. Suppression of carbonyl reductase expression enhances malignant behaviour in uterine cervical squamous cell carcinoma: carbonyl reductase predicts prognosis and lymph node metastasis.
Murakami A; Fukushima C; Yoshidomi K; Sueoka K; Nawata S; Yokoyama Y; Tsuchida S; Ismail E; Al-Mulla F; Sugino N
Cancer Lett; 2011 Dec; 311(1):77-84. PubMed ID: 21824723
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor.
Wei LH; Kuo ML; Chen CA; Cheng WF; Cheng SP; Hsieh FJ; Hsieh CY
Gynecol Oncol; 2001 Jul; 82(1):49-56. PubMed ID: 11426961
[TBL] [Abstract][Full Text] [Related]
12. Surgical excision promotes tumor growth and metastasis by promoting expression of MMP-9 and VEGF in a breast cancer model.
Zhao T; Xia WH; Zheng MQ; Lu CQ; Han X; Sun YJ
Exp Oncol; 2008 Mar; 30(1):60-4. PubMed ID: 18438343
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer.
Sato F; Shimada Y; Watanabe G; Uchida S; Makino T; Imamura M
Br J Cancer; 1999 Jul; 80(9):1366-72. PubMed ID: 10424737
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer.
Kanao H; Enomoto T; Kimura T; Fujita M; Nakashima R; Ueda Y; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Tanigami A; Yoshino K; Murata Y
Cancer Res; 2005 Oct; 65(19):8640-5. PubMed ID: 16204031
[TBL] [Abstract][Full Text] [Related]
15. Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer.
Güllü IH; Marangoz S
Br J Cancer; 1999 Aug; 80(11):1865. PubMed ID: 10468311
[No Abstract] [Full Text] [Related]
16. Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers.
Fujimoto J; Sakaguchi H; Hirose R; Ichigo S; Tamaya T
Br J Cancer; 1999 May; 80(5-6):827-33. PubMed ID: 10360662
[TBL] [Abstract][Full Text] [Related]
17. Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells.
Kato Y; Yamashita T; Ishikawa M
Oncol Rep; 2002; 9(3):565-9. PubMed ID: 11956628
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor exression in uterine cervical cancer: correlation with clinicopathologic characteristics and survival.
Goncharuk IV; Vorobjova LI; Lukyanova NY; Chekhun VF
Exp Oncol; 2009 Sep; 31(3):179-81. PubMed ID: 19783962
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer.
Hashimoto I; Kodama J; Seki N; Hongo A; Yoshinouchi M; Okuda H; Kudo T
Br J Cancer; 2001 Jul; 85(1):93-7. PubMed ID: 11437408
[TBL] [Abstract][Full Text] [Related]
20. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
